Lrp5/b-Catenin signaling controls lung macrophage differentiation and inhibits resolution of fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 56, Issue 2, 2017, Pages 191-201

  Sennello, Joseph A ^a   Misharin, Alexander V ^a   Flozak, Annette S ^a   Berdnikovs, Sergejs ^a   Cheresh, Paul ^a   Varga, John ^a   Kamp, David W ^a   Budinger, G R Scott ^a   Gottardi, Cara J ^a   Lam, Anna P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alveolar macrophage; Bleomycin; Lrp5; Lung fibrosis; catenin

Indexed keywords

BETA CATENIN; BLEOMYCIN; COLLAGENASE 3; GLYCOPROTEIN P 15095; INTERLEUKIN 13; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN F; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; IMMUNITY; IMMUNOLOGY; LUNG; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BLEOMYCIN; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; IMMUNITY; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MACROPHAGES, ALVEOLAR; MICE, INBRED C57BL; MYELOID CELLS; PULMONARY FIBROSIS; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; WNT SIGNALING PATHWAY;

EID: 85013131014     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2016-0147OC     Document Type: Article

References (66)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. [Published erratum appears in Lancet 381:628.].
2. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, Yona S. Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny. Nat Rev Immunol 2014;14:571-578.
3. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD1031 nonlymphoid dendritic cells. Immunity 2012;37:60-73.
4. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013;31: 563-604.
5. Poulin LF, Reyal Y, Uronen-Hansson H, Schraml BU, Sancho D, Murphy KM, Hakansson UK, Moita LF, Agace WW, Bonnet D, et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood 2012;119: 6052-6062.
6. van der Aa E, van Montfoort N, Woltman AM. BDCA31CLEC9A1 human dendritic cell function and development. Semin Cell Dev Biol 2015;41: 39-48.
7. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, et al. IRF4 transcription factor-dependent CD11b1 dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013;38: 970-983.
8. Kim TH, Lee HK. Differential roles of lung dendritic cell subsets against respiratory virus infection. Immune Netw 2014;14: 128-137.
9. Tsoumakidou M, Tousa S, Semitekolou M, Panagiotou P, Panagiotou A, Morianos I, Litsiou E, Trochoutsou AI, Konstantinou M, Potaris K, et al. Tolerogenic signaling by pulmonary CD1c1 dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. J Allergy Clin Immunol 2014;134:944-954.e8.
10. Takenaka MC, Quintana FJ. Tolerogenic dendritic cells. Semin Immunopathol [online ahead of print] 19 Sep 2016; DOI:10.1007/s00281-016-0587-8.
11. Condon TV, Sawyer RT, Fenton MJ, Riches DW. Lung dendritic cells at the innate-Adaptive immune interface. J Leukoc Biol 2011;90: 883-895.
12. Lommatzsch M, Kraeft U, Troebs L, Garbe K, Bier A, Stoll P, Klammt S, Kuepper M, Bratke K, Virchow JC. Fluticasone impact on airway dendritic cells in smokers: A randomized controlled trial. Respir Res 2013;14:114.
13. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-Airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
14. Stoll P, Heinz AS, Bratke K, Bier A, Garbe K, Kuepper M, Virchow JC, Lommatzsch M. Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD. Respir Res 2014;15:48.
15. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:998-1005.
16. Freeman CM, Martinez FJ, H an MK, Ames TM, Chensue SW, Todt JC, Arenberg DA, Meldrum CA, Getty C, McCloskey L, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:1179-1188.
17. Vassallo R, Walters PR, Lamont J, Kottom TJ, Yi ES, Limper AH. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res 2010; 11:45.
18. Arellano-Orden E, Calero-Acuña C, Moreno-Mata N, Gómez-Izquierdo L, Sánchez-Ló pez V, Ló pez-Raḿirez C, Tobar D, López-Villalobos JL, Gutié rrez C, Blanco-Orozco A, et al. Cigarette smoke decreases the maturation of lung myeloid dendritic cells. PLoS One 2016;11: E0152737.
19. Osterholzer JJ, Ames T, Polak T, Sonstein J, Moore BB, Chensue SW, Toews GB, Curtis JL. CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J Immunol 2005; 175:874-883.
20. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Ma R, Murray LA, Tsui P, Lou J, Marks JD, Baron . TGF-b-dependent dendritic cell chemokinesis in murine models of airway disease. J Immunol 2015;195:1182-1190.
21. Bracke KR, D'Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006;177:4350-4359.
22. Hashimoto M, Yanagisawa H, Minagawa S, Sen D, Goodsell A, Ma R, Moermans C, McKnelly KJ, Baron JL, Krummel MF, et al. A critical role for dendritic cells in the evolution of IL-1b-mediated murine airway disease. J Immunol 2015;194:3962-3969.
23. Singh B, Arora S, Khanna V. Association of severity of COPD with IgE and interleukin-1b. Monaldi Arch Chest Dis 2010;73: 86-87.
24. Brand OJ, Somanath S, Moermans C, Yanagisawa H, Hashimoto M, Cambier S, Markovics J, Bondesson AJ, Hill A, Jablons D, et al. Transforming growth factor-b and interleukin-1b signaling pathways converge on the chemokine CCL20 promoter. J Biol Chem 2015; 290:14717-14728.
25. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, et al. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin avb8-mediated activation of TGF-b. J Clin Invest 2011;121:2863-2875.
26. Veres TZ, Voedisch S, Spies E, Tschernig T, Braun A. Spatiotemporal and functional behavior of airway dendritic cells visualized by twophoton microscopy. Am J Pathol 2011;179:603-609. [Published erratum appears in Am J Pathol 179:2674.].
27. Thornton EE, Looney MR, Bose O, Sen D, Sheppard D, Locksley R, Huang X, Krummel MF. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J Exp Med 2012;209:1183-1199.
28. Du RH, Richmond BW, Blackwell TS Jr, Cates JM, Massion PP, Ware LB, Lee JW, Kononov AV, Lawson WE, Blackwell TS, et al. Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic o bstructive pulmonary disease. Virchows Arch 2015;467:657-665.
29. Suzuki Y, Suda T, Furuhashi K, Shibata K, Hashimoto D, Enomto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, et al. Mouse CD11bhigh lung dendritic cells have more potent capability to induce IgA than CD1031 lung dendritic cells in vitro. Am J Respir Cell Mol Biol 2012;46:773-780.
30. Ladjemi MZ, Lecocq M, Weynand B, Bowen H, Gould HJ, Van Snick J, Detry B, Pilette C. Increased IgA production by B-cells in COPD via lung epithelial interleukin-6 and TACI pathways. Eur Respir J 2015; 45:980-993.
31. Richmond BW, Brucker RM, Han W, Du RH, Zhang Y, Cheng DS, Gleaves L, Abdolrasulnia R, Polosukhina D, Clark PE, et al. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency. Nat Commun 2016;7: 11240.
32. Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 2012;7:e31976.
33. Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, et al. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest 2013;144:498-506.
34. Brown MB, Hunt WR, Noe JE, Rush NI, Schweitzer KS, Leece TC, Moldobaeva A, Wagner EM, Dudek SM, Poirier C, et al. Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke. Pulm Circ 2014;4:260-268.
35. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 2012;26:533-545.
36. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J 2009;34:219-230.
37. Halle S, Dujardin HC, Bakocevic N, Fleige H, Danzer H, Willenzon S, Suezer Y, Hämmerling G, Garbi N, Sutter G, et al. Induced bronchusassociated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 2009;206:2593-2601.
38. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, Elewaut D, Osterhaus AD, Hendriks R, Rimmelzwaan GF, Lambrecht BN. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009;206:2339-2349.
39. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, Schwarz P, Armulik A, Browning JL, Tallquist M, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012;150: 194-206.
40. Polverino F, Cosio BG, Pons J, Laucho-Contreras M, Tejera P, Iglesias A, Rios A, Jahn A, Sauleda J, Divo M, et al. B cell-Activating factor. An orchestrator of lymphoid follicles in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;192:695-705.
41. Seys LJ, Verhamme FM, Schinwald A, Hammad H, Cunoosamy DM, Bantsimba-Malanda C, Sabirsh A, McCall E, Flavell L, Herbst R, et al. Role of B cell-Activating factor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;192:706-718.
42. Litsiou E, Semitekolou M, Galani IE, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, et al. CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:1194-1202.
43. Hwang JY, Randall TD, Silva-Sanchez A. Inducible bronchusassociated lymphoid tissue: Taming inflammation in the lung. Front Immunol 2016;7:258.
44. Fleige H, Ravens S, Moschovakis GL, Bölter J, Willenzon S, Sutter G, Häussler S, Kalinke U, Prinz I, Förster R. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med 2014;211:643-651.
45. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L, Kolls JK, Khader SA, Randall TD. The development of inducible bronchus-Associated lymphoid tissue depends on IL-17. Nat Immunol 2011;12:639-646.
46. Roos AB, Sandé n C, Mori M, Bjermer L, Stampfli MR, Erjefält JS. IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis. Am J Respir Crit Care Med 2015;191:1232-1241.
47. Fujii U, Miyahara N, Taniguchi A, Waseda K, Morichika D, Kurimoto E, Koga H, Kataoka M, Gelfand EW, Cua DJ, et al. IL-23 is essential for the development of elastase-induced pulmonary inflammation and emphysema. Am J Respir Cell Mol Biol 2016;55:697-707.
48. Olloquequi J, Montes JF, Prats A, Rodŕiguez E, Montero MA, Garćia-Valero J, Ferrer J. Significant increase of CD571 cells in pulmonary lymphoid follicles of COPD patients. Eur Respir J 2011;37:289-298.
49. Freeman CM, Stolberg VR, Crudgington S, Martinez FJ, Han MK, Chensue SW, Arenberg DA, Meldrum CA, McCloskey L, Curtis JL. Human CD561 cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease. Plos One 2014;9: E103840.
50. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007;26:503-517.
51. Stolberg VR, Martin B, Mancuso P, OlszewskiMA, Freeman CM, Curtis JL, Chensue SW. Role of CC chemokine receptor 4 in natural killer cell activation during acute cigarette smoke exposure. Am J Pathol 2014; 184:454-463.
52. Mori M, Andersson CK, Svedberg KA, Glader P, Bergqvist A, Shikhagaie M, Löfdahl CG, Erjefält JS. Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease. Thorax 2013;68:521-531.
53. Furuhashi K, Suda T, Hasegawa H, Suzuki Y, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shibata K, et al. Mouse lung CD1031 and CD11bhigh dendritic cells preferentially induce distinct CD41 T-cell responses. Am J Respir Cell Mol Biol 2012;46: 165-172.
54. Shan M, Cheng HF, Song LZ, Roberts L, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Storness-Bliss C, et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 2009;1:4ra10.
55. Freeman CM, McCubbrey AL, Crudgington S, Nelson J, Martinez FJ, Han MK, Washko GR Jr, Chensue SW, Arenberg DA, Meldrum CA, et al. Basal gene expression by lung CD41 T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent. Plos One 2014;9:e96421.
56. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
57. Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. Plos One 2011;6:e16245.
58. Barceló B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agustí AG. Phenotypic characterisation of T-lymphocytes in COPD: Abnormal CD41CD251 regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008;31:555-562.
59. Plumb J, Smyth LJ, Adams HR, Vestbo J, Bentley A, Singh SD. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009;34:89-94.
60. Foo SY, Zhang V, Lalwani A, Lynch JP, Zhuang A, Lam CE, Foster PS, King C, Steptoe RJ, Mazzone SB, et al. Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation. J Immunol 2015;194:4567-4576.
61. Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front Immunol 2014;5:131.
62. Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 2015;15:471-485.
63. Bratke K, Klug M, Bier A, Julius P, Kuepper M, Virchow JC, Lommatzsch M. Function-Associated surface molecules on airway dendritic cells in cigarette smokers. Am J Respir Cell Mol Biol 2008;38:655-660.
64. Rogers AV, Adelroth E, Hattotuwa K, Dewar A, Jeffery PK. Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: An electron microscopic study. Thorax 2008;63:108-114.
65. Tsoumakidou M, Koutsopoulos AV, Tzanakis N, Dambaki K, Tzortzaki E, Zakynthinos S, Jeffery PK, Siafakas NM. Decreased small airway and alveolar CD831 dendritic cells in COPD. Chest 2009;136: 726-733.
66. Van Pottelberge GR, Bracke KR, Demedts IK, De Rijck K, Reinartz SM, van Drunen CM, Verleden GM, Vermassen FE, Joos GF, Brusselle GG. Selective accumulation of langerhans-Type dendritic cells in small airways of patients with COPD. Respir Res 2010;11:35.